● Resources ● Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial
Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial
Important notice regarding use of cookies: Our Privacy Policy reflects our use of cookies to collect and process data. By continuing to use this website, you agree to use our cookies and similar technologies as described in our Privacy Policy.